cagrisema combination semaglutide cagrilintide phase 3 results 2025 Novo Nordisk's outperforms Ozempic in III trial How much weight can you
How much weight can you lose with cagrisema? Another obesity contender just raised the stakes. Novo Nordisk's CagriSema combination delivered around 20% mean weight loss in a large trial. The formula combines semaglutide with cagrilintide, giving the body multiple appetite control CagriSema Outperforms Semaglutide Alone Across Phase 3 REIMAGINE Trials HCPLive Novo Nordisk to present array of new portfolio data including studies with semaglutide and CagriSema, expanding evidence in obesity and diabetes care at ADA 2025
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15


